These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 7265168)

  • 1. An intracellular structure in Bacteroides fragilis.
    Reid JH
    J Med Microbiol; 1981 Aug; 14(3):345-6. PubMed ID: 7265168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular polysaccharide of Bacteroides fragilis.
    Lindner JG; Marcelis JH; de Vos NM; Hoogkamp-Korstanje JA
    J Gen Microbiol; 1979 Mar; 111(1):93-9. PubMed ID: 37285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phagocytic and serum killing of capsulate and non-capsulate Bacteroides fragilis.
    Reid JH; Patrick S
    J Med Microbiol; 1984 Jun; 17(3):247-57. PubMed ID: 6726784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scanning electron microscopic examination of Bacteroides fragilis and Gardnerella vaginalis after exposure to concentration gradients of metronidazole and tinidazole.
    Skarin A; Mårdh PA
    Scand J Infect Dis Suppl; 1981; 26():54-9. PubMed ID: 6972572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunochemical characterization of a polysaccharide antigen of Bacteroides fragilis with an IgM monoclonal antibody.
    Reid JH; Patrick S; Tabaqchali S
    J Gen Microbiol; 1987 Jan; 133(1):171-9. PubMed ID: 3309142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antibacterial activity of cefotetan against Bacteroides fragilis group clinical isolates.
    Menozzi M; Avanzini P; Lecchini R; Bigi M; Chezzi C
    Chemioterapia; 1987 Jun; 6(2 Suppl):88-91. PubMed ID: 3509541
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cytomorphological study of the action of ornidazole against Bacteroides fragilis].
    Attisso MA; Dusart G; Simeon De Buochberg M; Zuccarelli M
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):813-8. PubMed ID: 3309820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric analysis of within-strain variation in polysaccharide expression by Bacteroides fragilis by use of murine monoclonal antibodies.
    Lutton DA; Patrick S; Crockard AD; Stewart LD; Larkin MJ; Dermott E; McNeill TA
    J Med Microbiol; 1991 Oct; 35(4):229-37. PubMed ID: 1719202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection with Bacteroides fragilis: pathogenesis and immunoprophylaxis in an animal model.
    Kasper DL; Onderdonk AB
    Scand J Infect Dis Suppl; 1982; 31():28-33. PubMed ID: 6954635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenicity of the Bacteroides fragilis group.
    Brook I
    Ann Clin Lab Sci; 1989; 19(5):360-76. PubMed ID: 2679351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial activity of SMAP-29 against the Bacteroides fragilis group and clostridia.
    Arzese A; Skerlavaj B; Tomasinsig L; Gennaro R; Zanetti M
    J Antimicrob Chemother; 2003 Sep; 52(3):375-81. PubMed ID: 12917245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foreign-body-associated experimental osteomyelitis induced with Bacteroides fragilis and Staphylococcus epidermidis in rabbits.
    Lambe DW; Ferguson KP; Mayberry-Carson KJ; Tober-Meyer B; Costerton JW
    Clin Orthop Relat Res; 1991 May; (266):285-94. PubMed ID: 2019061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface vesicles: a possible function in commensal relations of Bacteroides fragilis.
    Domingues RM; Silva e Souza W das G; Moraes SR; Avelar KE; Hirata Júnior R; Fonseca ME; Ferreira MC
    Zentralbl Bakteriol; 1997 Apr; 285(4):509-17. PubMed ID: 9144912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-antibiotic effect in Bacteroides fragilis group.
    Siverhus DJ; Edmiston CE; Clausz JC; Goheen MP
    Ann Clin Lab Sci; 1988; 18(4):326-36. PubMed ID: 3165611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile salts enhance bacterial co-aggregation, bacterial-intestinal epithelial cell adhesion, biofilm formation and antimicrobial resistance of Bacteroides fragilis.
    Pumbwe L; Skilbeck CA; Nakano V; Avila-Campos MJ; Piazza RM; Wexler HM
    Microb Pathog; 2007; 43(2-3):78-87. PubMed ID: 17524609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface structures, haemagglutination and cell surface hydrophobicity of Bacteroides fragilis strains.
    Oyston PC; Handley PS
    J Gen Microbiol; 1990 May; 136(5):941-8. PubMed ID: 1696307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homogeneity of the morphological groups of bacteriophages infecting Bacteroides fragilis strain HSP40 and strain RYC2056.
    Queralt N; Jofre J; Araujo R; Muniesa M
    Curr Microbiol; 2003 Mar; 46(3):163-8. PubMed ID: 12567237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple technique useful for clinical laboratory testing for invasive potential applied to Bacteroides fragilis.
    Goldner M; Carlier JP
    Microbiologica; 1990 Oct; 13(4):333-7. PubMed ID: 2087201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the antigenic composition of the fragilis group of Bacteroides.
    Elhag KM; Alkarmi TO
    J Med Microbiol; 1991 Aug; 35(2):118-22. PubMed ID: 1875392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide evidence of positive selection in Bacteroides fragilis.
    Yoshizaki S; Umemura T; Tanaka K; Watanabe K; Hayashi M; Muto Y
    Comput Biol Chem; 2014 Oct; 52():43-50. PubMed ID: 25215651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.